Nurse Practitioner in Oak Forest, IL Accepting Medicare

6 Nurse Practitioner nurses found. Showing 1 - 6

Krystle Banzuela, FNP-BC Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 6360 W 159th St, Suite A & B, Oak Forest, IL 60452 Phone: 708-687-4620

Housamedain Amir, APRN, FNP-BC Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 5905 Condado Dr, Oak Forest, IL 60452 Phone: 708-337-9335

Christopher Ryan Speaker, APN, FNP-BC Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 5700 Edward Dr, Oak Forest, IL 60452 Phone: 708-535-0364    Fax: 773-702-1192

Ms. Shannon L Casey, MSN, FNP-BC Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 4924 149th St, Oak Forest, IL 60452 Phone: 708-341-1398

Franchesca Maxie Hammond, Nurse Practitioner - Psych/Mental Health Medicare: Medicare Enrolled Practice Location: 6006 159th St Ste 2a, Oak Forest, IL 60452 Phone: 773-749-8691    Fax: 773-800-7968

Debra L Bennett Carey, APRN Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 16493 Brenden Ln, Oak Forest, IL 60452 Phone: 708-668-7342

News Archive

EuroPCR 2017 brings together interventional cardiologists to celebrate success and develop innovations

EuroPCR 2017, the official annual meeting of the European Association for Percutaneous Cardiovascular Interventions, pushed back barriers in bringing together young and established interventional cardiologists to learn from past successes, build understanding and experience of new percutaneous interventional approaches, and develop innovations for the future at this year's course held from 16 to 19 May 2017 at the Palais des Congrès in Paris, France.

Alere Determine HIV-1/2 Ag/Ab Combo test receives CLIA Waiver from FDA

Alere Inc., a global leader in rapid diagnostic tests, today announced that the U.S. Food and Drug Administration (FDA) has granted CLIA (Clinical Laboratory Improvement Amendments) Waiver for the Alere Determine™ HIV-1/2 Ag/Ab Combo test.

Portrazza approved to treat patients with advanced squamous non-small cell lung cancer

The U.S. Food and Drug Administration today approved Portrazza (necitumumab) in combination with two forms of chemotherapy to treat patients with advanced (metastatic) squamous non-small cell lung cancer (NSCLC) who have not previously received medication specifically for treating their advanced lung cancer.

Murray valley encephalitis surfaces after 37 years

A fatal and severe form of mosquito borne viral brain infection has been detected in the Riverina Murray region of New South Wales. Murray Valley encephalitis has affected sentinel chicken flocks in the northern Victorian towns of Mildura, Robinvale, Kerang and Barmah as well in the New South Wales town of Tooleybuc, near Swan Hill. The virus has not been diagnosed in a Victorian for 37 years said Victoria's Chief Health Officer Dr John Carnie. He said although the virus had not been detected in a human, Victorians living along the Murray River should avoid being bitten by mosquitoes.

Read more Medical News

› Verified 4 days ago